SBIR/STTR Research Award
1,2-NAPHTHOQUINONE DERIVATIVES IN TRICHOMONAS THERAPY
Award amount
$100,000Program and phase
SBIR · Phase IAward year
1999Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- SLIL BIOMEDICAL CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Not Available This program will provide a unique low-cost propulsion system for the Low Cost Autonomous Attack System (LOCAAS) weapon and other smart miniature munition systems. The initial phase of this program will start prior to the SBIR program and will be supported by commercial funding to accelerate the schedule for the design and hardware fabrication. The commercial funding will continue on a parallel basis during the SBIR Phase I effort so that this development program can keep pace with a critical vehicle development schedule. The combined program will provide operational engine-generator hardware that is ready for performance development and environmental testing during the SBIR Phase II portion of the program. This new turbojet engine will use existing production turbocharger rotating components, and a direct shaft mounted generator that will provide all of the vehicle electrical power for the 30-minute operating life. The engine will be configured from a proven base technology that has already demonstrated the features of compact configuration, easy starting, and fuel lubricated bearings. The current state-of-the-art for the cost of these small engines is 20% of the total vehicle cost, and the long-range cost objective for this engine system is to approach 10% of the total vehicle cost.
Technology keywords
Not reported